Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear transport factor 2 pseudogene 3 (NUTF2P3) is classified as a human pseudogene; this means it is a DNA sequence similar to a gene but non-functional as a protein-coding gene. It is related by sequence to the functional gene called NUTF2 (nuclear transport factor 2), which encodes a protein involved in the import of proteins into the nucleus via the nuclear pore complex by interaction with Ran GTPase[2][5]. However, pseudogenes like NUTF2P3 typically do not produce a functional protein, are not considered therapeutic targets, and have no known biological function, disease association, or utility as a biomarker. ## Context and Rationale - The search results provide detailed information about NUTF2 (the protein-coding gene, not the pseudogene); there is no specific data on "nuclear transport factor 2 pseudogene 3" (NUTF2P3), consistent with the general status of many pseudogenes in the human genome. - NUTF2P3 is not a therapeutic target (i.e., not a receptor, enzyme, transporter, or similar functional molecule)[2][5]. - No aliases or alternative names are widely established for this pseudogene, nor is there evidence that it participates in biological pathways, acts in disease, or is targeted by drugs. ## Notes - Do not confuse NUTF2P3 with the functional gene NUTF2; only NUTF2 produces a protein with defined roles in nuclear transport[2][5]. - If your interest is in the protein-coding NUTF2, refer to it without the "pseudogene" designation, and use relevant functional and disease association data[2][4]. ## Summary for Data Structuring - NUTF2P3 is a pseudogene, not a functional gene or target; entries for biological functions, drug interactions, disease role, or biomarkers are not applicable. - The entry is incorrect as a therapeutic target; use NUTF2 instead if you require data on a functional, druggable nuclear transport factor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear transport factor 2 pseudogene 3 (NUTF2P3).